Drug Profile
BILB 1941
Alternative Names: BILB 1941 ZW; BILB1941; BILN-1941Latest Information Update: 16 Oct 2014
Price :
$50
*
At a glance
- Originator Boehringer Ingelheim
- Class Antivirals
- Mechanism of Action Hepatitis C virus NS 5 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hepatitis C
Most Recent Events
- 01 Oct 2014 Discontinued - Phase-I for Hepatitis C (In volunteers) in Germany (PO, tablet)
- 01 Oct 2014 Discontinued - Phase-II for Hepatitis C in France, Germany and Spain (PO, solution)
- 01 Apr 2006 Boehringer Ingelheim completes a phase II trial in Hepatitis C in France, Germany and Spain (NCT02254707)